Tisztelt Kollégák!

Minden érdeklődőt szeretettel várunk Zalakaroson, 2019. szeptember 19-21. között a Magyar Stroke Társaság XIV. Kongresszusán és a Magyar Neuroszonológiai Társaság XI. Konferenciáján.

Időtábla

Program és poszterlista

A Konferencia helyszíne: Park Inn Zalakaros Resort & Spa (8749 Zalakaros, Üdülő sor 1.)

A Konferencia témái:

Praehospitális ellátás és stroke ellátás szervezés.
Telemedicina a stroke ellátásban.
Akut stroke ellátás kérdései
Acut endovascularis műtéti ellátás
Korszerű képalkotó és elektrofiziológiai módszerek acut stroke-ban
Stroke preventio, a szekunder prevenció fejlődése
Heart and Brain.
Kardiogén stroke-ok invazív ellátása
Anticoagulálás a stroke megelőzéséért
Forró témák a vérzéses agyi kórképek ellátása címen
Nagy nemzetközi klinikai vizsgálatok
Stroke rizikófaktorok, és menedzselésük
A nyaki nagyér revascularisatio aktuális kérdései
Vascularis idegsebészet
Neuroszonológia
Alapkutatás, experimentális preklinikai vizsgálatok
Vascularis biológia,
Stroke genetika
Kisérőbetegségek, kognitív funkció károsodása
Ritka etiológiájú stroke-ok
Stroke és epilepsia
Stroke-rehabilitáció
Post stroke állapotok
Szabad témák, Esetbörze

További információ: http://www.altagra.hu/stroke

A Magyar Stroke Társaság és a Magyar Neuroszonológiai Társaság elnöksége nevében:

Dr. Németh László
főszervező

Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.

This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.

Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice 
• Assessing cardiovascular risk 
• Obesity as a treatable condition 
• Instilling confidence in patients in using injectables 
• New formulations on the horizon

How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.

To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.

Invitation

Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.

This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.

Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice 
• Assessing cardiovascular risk 
• Obesity as a treatable condition 
• Instilling confidence in patients in using injectables 
• New formulations on the horizon

How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.

To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.

Invitation

Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.

This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.

Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice 
• Assessing cardiovascular risk 
• Obesity as a treatable condition 
• Instilling confidence in patients in using injectables 
• New formulations on the horizon

How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.

To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.

Invitation